U.S. flag

An official website of the United States government

NM_014384.3(ACAD8):c.940-13C>G AND Deficiency of isobutyryl-CoA dehydrogenase

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 8, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003855162.2

Allele description [Variation Report for NM_014384.3(ACAD8):c.940-13C>G]

NM_014384.3(ACAD8):c.940-13C>G

Gene:
ACAD8:acyl-CoA dehydrogenase family member 8 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q25
Genomic location:
Preferred name:
NM_014384.3(ACAD8):c.940-13C>G
HGVS:
  • NC_000011.10:g.134261725C>G
  • NG_015842.1:g.13186C>G
  • NM_014384.3:c.940-13C>GMANE SELECT
  • LRG_448:g.13186C>G
  • NC_000011.9:g.134131619C>G
Molecular consequence:
  • NM_014384.3:c.940-13C>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Deficiency of isobutyryl-CoA dehydrogenase
Synonyms:
ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF; IBD deficiency; Acyl-CoaA dehydrogenase family, member 8, deficiency of
Identifiers:
MONDO: MONDO:0012648; MedGen: C1969809; Orphanet: 79159; OMIM: 611283

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004663379Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Mar 8, 2023) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004663379.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has been observed in individual(s) with isobutyryl-CoA dehydrogenase deficiency (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 8 of the ACAD8 gene. It does not directly change the encoded amino acid sequence of the ACAD8 protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024